Salicylic acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of warts. It is to be applied as a small amount of the wart removal cream directly to the wart, ensuring that contact with surrounding healthy skin is avoided.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For the removal of common and plantar warts, an appropriate amount of the product should be applied directly to the wart.

Common warts are characterized by their rough, "cauliflower-like" appearance on the surface, making them easily identifiable. In contrast, plantar warts are located exclusively on the bottom of the foot and are distinguished by tenderness and disruption of the footprint pattern.

Healthcare professionals should ensure that the application is performed with care, targeting the wart while avoiding surrounding healthy skin. The frequency and duration of treatment may vary based on individual response and the specific characteristics of the wart. Regular monitoring of the treatment area is recommended to assess efficacy and any potential adverse reactions.

Contraindications

Use of this product is contraindicated in the following situations:

Pregnant individuals should consult a healthcare professional prior to use due to potential risks to the fetus. Similarly, breastfeeding individuals are advised to seek medical advice before using this product to ensure safety for the nursing infant. Additionally, this product should be used by children only under adult supervision to mitigate any risks associated with unsupervised use.

Warnings and Precautions

For external use only, this product is flammable and must be kept away from fire and flame. It is contraindicated for application on irritated skin, infected areas, or on the face and mucous membranes. Caution is advised for individuals with diabetes or poor blood circulation, as use in these populations is not recommended.

Healthcare professionals should advise patients to consult a physician prior to use if they are pregnant or breastfeeding. Additionally, it is essential that children use this product only under adult supervision to ensure safety.

Patients should be instructed to discontinue use and seek medical advice if discomfort persists. Monitoring for any adverse reactions is crucial to ensure patient safety and efficacy of the treatment.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire and flame. It is contraindicated for use on irritated skin or on any area that is infected or reddened, including the face and mucous membranes. Additionally, the product is not recommended for individuals with diabetes or poor blood circulation.

In the event of persistent discomfort, patients are advised to stop use and consult a healthcare professional.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ttsiya Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product under adult supervision to ensure safe administration and adherence to recommended guidelines. It is essential to keep the product out of reach of children to prevent accidental ingestion or misuse.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider prior to use.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication while breastfeeding. There is no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate management in the event of an overdose.

Nonclinical Toxicology

The use of this product during pregnancy should be approached with caution, and individuals are advised to consult a healthcare professional prior to use if they are pregnant.

This product is not recommended for individuals with diabetes or those experiencing poor blood circulation, as these conditions may exacerbate potential adverse effects.

No relevant information is available regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children and ensure that children use it only under adult supervision. It is important for patients to consult a doctor before using the product if they are pregnant or breastfeeding.

Patients should be informed to stop using the product and seek medical advice if discomfort persists. Additionally, when using this product, patients should be cautioned to avoid contact with the eyes. In the event that the product comes into contact with the eyes, they should flush the eyes with water for 15 minutes and avoid inhaling any vapors. Providers should also recommend that patients cap the product tightly and store it at room temperature, away from heat sources.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from heat sources, to maintain its integrity and effectiveness. After each use, it is essential to cap the container tightly to prevent contamination and preserve the product's quality.

Additional Clinical Information

The product is administered cutaneously. Clinicians should advise patients to consult a doctor prior to use if they are pregnant or breastfeeding. It is recommended that children use the product under adult supervision. Patients should discontinue use and seek medical advice if discomfort persists. While using the product, it is important to avoid contact with the eyes; in case of contact, the eyes should be flushed with water for 15 minutes, and inhalation of vapors should be avoided. Additionally, patients should ensure the cap is tightly closed and store the product at room temperature, away from heat.

Drug Information (PDF)

This file contains official product information for Ttsiya Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)